Downregulation of AKT is a well-known effect of NFV and has been associated with impaired glucose metabolism, insulin resistance, and lipodystrophy during chronic treatment, which are reversible upon discontinuation of the therapy [9]. The gene discussed is AKT1; the disease is Insulin resistance.